Baxter International Inc. vs Eli Lilly & Co.
BAX vs LLY — side-by-side comparison from reported financials. BAX leads 2, LLY leads 9 of 11 comparable metrics.
Baxter International Inc.
BAX · Healthcare
$24.35+1.88%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | BAX | LLY |
|---|---|---|
| Price | $24.35 | $1 177.20 |
| Market cap | $12.6B | $1.05T |
| Revenue (TTM) | $11.5B | $79.7B |
| Revenue growth | -9.4% | +31.7% |
| Net margin | -9.3% | 33.5% |
| Free cash flow | $931M | $18.2B |
| Net cash (debt) | $1.97B | ($35.2B) |
| 1-year price return | +8.2% | +37.6% |
| P/E | — | 41.6 |
| P/E vs own history (cheap-side %) | 9% | 88% |
| Dividend yield | 1.46% | 0.52% |
| Return on equity | -17% | 93% |
| Altman Z-score | 2.12 | 7.10 |
| CV checks passed | 8 of 10 | 11 of 10 |
| Employees | 37,500 | 50,000 |
Full résumé-style profiles: BAX CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.